End-to-end pharmacovigilance services delivering regulatory compliance, patient safety monitoring, and risk management excellence across global markets with ISO-certified quality standards.
End-to-end pharmacovigilance solutions delivering regulatory compliance, patient safety monitoring, and risk management excellence
Complete lifecycle management ensuring MAHs remain compliant with EU/EEA legal requirements.
Rapidly expanding network of experienced QPPVs and LPPVs supporting global market entry strategies.
End-to-end case management with 100% QC and pharmacovigilance physician review.
Weekly and ongoing searches with systematic identification and processing of literature-derived ICSRs.
AI-powered analysis with disproportionality methods, clinical review, and complete signal lifecycle management.
Complete authoring of PBRERs, PSURs, DSURs, ASRs, SBRs with calendar management and compliance monitoring.
Significant cost reduction without compromising quality, delivering ISO-certified workflows with 99.8% data accuracy.
Cost savings result from shared infrastructure, specialized expertise, scalable resources, and operational efficiencies. Eliminate personnel, system licenses, and infrastructure costs.
Fully functional pharmacovigilance system implemented in 30 days for companies facing immediate regulatory action or license suspension risks.
Addressing urgent compliance needs amid intensified regulatory enforcement in Indian pharmaceutical market.
Comprehensive RMP authoring with safety specifications, pharmacovigilance plans, and innovative risk minimization strategies
EU RMP and FDA REMS preparation meeting regulatory requirements across global jurisdictions.
Important identified risks, potential risks, and missing information with comprehensive characterization.
Routine and additional PV activities including PASS, enhanced monitoring, registries, and targeted surveillance.
Routine measures (product information, legal status) and additional aRMMs targeting specific safety concerns.
European Risk Management Plans
Risk Evaluation & Mitigation Strategies
Additional Risk Minimization
Analysis & Optimization
Comprehensive materials for healthcare professionals and patients with user testing and effectiveness analysis.
Urgent safety communications to prescribers with clear action recommendations and reporting mechanisms.
Direct Healthcare Professional Communications
Regulatory consultation and stakeholder review
Plain language materials with health literacy assessment
Customized SDEAs with complete reconciliation and compliance monitoring across global partnerships
Customized Safety Data Exchange Agreements tailored to country-specific regulatory requirements.
Regular reconciliation procedures ensuring complete data exchange and partner compliance.
Leveraging AI, machine learning, and automation to deliver superior safety monitoring and regulatory compliance
Predictive signal detection and automated case processing with continuous learning from historical data.
Comprehensive visibility into operations, compliance metrics, and quality indicators with automated alerts.
Seamless connectivity with global safety databases and regulatory portals with complete audit trails.
NLP-powered extraction from unstructured sources with automated coding, duplicate detection, and quality checks.
From MedWatch forms, HCP letters, and patient reports
MedDRA and WHO-DD automated coding support
Duplicate detection and data quality checks
ISO-certified workflows delivering 99.8% data accuracy with comprehensive audit and inspection readiness
Standardized processes with continuous improvement and QMS implementation.
Comprehensive Good Pharmacovigilance Practice audits and self-inspections.
Root cause analysis with corrective and preventive action implementation.
System assessments against regulatory requirements and best practices.
Expert knowledge and proven track record across global regulatory frameworks.
15-day and 90-day reporting via Sugam Portal with zero-tolerance compliance
MedWatch reporting, REMS implementation, and FDA safety inquiry responses
GVP Module compliance and national competent authority requirements
E2A through E2F implementation for multi-regional compliance
Comprehensive coverage across India with international expertise in multiple regions.
EU, CIS Countries, MENA, and LATAM regional coverage
Comprehensive QMS development and implementation with ICH Q9 quality risk management principles.
Complete suite of regulatory-compliant SOPs covering all pharmacovigilance processes with periodic review and updates.
Expert medical writing delivering high-quality regulatory and scientific documentation with physician review and validation
All documents undergo rigorous medical review by qualified pharmacovigilance physicians ensuring clinical accuracy, regulatory compliance, and scientific rigor.
Partner with Cliorbit for comprehensive drug safety solutions that deliver regulatory compliance, patient protection, and operational excellence with proven cost savings.